These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17070883)

  • 61. The L protein of Rift Valley fever virus can rescue viral ribonucleoproteins and transcribe synthetic genome-like RNA molecules.
    Lopez N; Muller R; Prehaud C; Bouloy M
    J Virol; 1995 Jul; 69(7):3972-9. PubMed ID: 7769655
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The C-terminal region of Rift Valley fever virus NSm protein targets the protein to the mitochondrial outer membrane and exerts antiapoptotic function.
    Terasaki K; Won S; Makino S
    J Virol; 2013 Jan; 87(1):676-82. PubMed ID: 23097454
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The carboxy-terminal acidic domain of Rift Valley Fever virus NSs protein is essential for the formation of filamentous structures but not for the nuclear localization of the protein.
    Yadani FZ; Kohl A; Préhaud C; Billecocq A; Bouloy M
    J Virol; 1999 Jun; 73(6):5018-25. PubMed ID: 10233964
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Sequence analysis of the medium (M) segment of Cache Valley virus, with comparison to other Bunyaviridae.
    Brockus CL; Grimstad PR
    Virus Genes; 1999; 19(1):73-83. PubMed ID: 10499453
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Genetic subpopulations of Rift Valley fever virus strains ZH548 and MP-12 and recombinant MP-12 strains.
    Lokugamage N; Freiberg AN; Morrill JC; Ikegami T
    J Virol; 2012 Dec; 86(24):13566-75. PubMed ID: 23035230
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Yeast Expression and Activity Assay of RVFV Polymerase.
    Wang X; Tang L; Chen E; Chen Z
    Methods Mol Biol; 2024; 2824():335-345. PubMed ID: 39039421
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Protein synthesis in Rift Valley fever virus-infected cells.
    Struthers JK; Swanepoel R; Shepherd SP
    Virology; 1984 Apr; 134(1):118-24. PubMed ID: 6710870
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Replication of hemorrhagic fever viruses in monocytic cells.
    Lewis RM; Morrill JC; Jahrling PB; Cosgriff TM
    Rev Infect Dis; 1989; 11 Suppl 4():S736-42. PubMed ID: 2665010
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Rift valley fever virus L protein forms a biologically active oligomer.
    Zamoto-Niikura A; Terasaki K; Ikegami T; Peters CJ; Makino S
    J Virol; 2009 Dec; 83(24):12779-89. PubMed ID: 19812169
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Synthesis, proteolytic processing and complex formation of N-terminally nested precursor proteins of the Rift Valley fever virus glycoproteins.
    Gerrard SR; Nichol ST
    Virology; 2007 Jan; 357(2):124-33. PubMed ID: 16963099
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Visualizing the ribonucleoprotein content of single bunyavirus virions reveals more efficient genome packaging in the arthropod host.
    Bermúdez-Méndez E; Katrukha EA; Spruit CM; Kortekaas J; Wichgers Schreur PJ
    Commun Biol; 2021 Mar; 4(1):345. PubMed ID: 33753850
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Biochemical characterization of Rift Valley fever virus.
    Rice RM; Erlick BJ; Rosato RR; Eddy GA; Mohanty SB
    Virology; 1980 Aug; 105(1):256-60. PubMed ID: 7414952
    [No Abstract]   [Full Text] [Related]  

  • 73. Rift Valley fever virus in mice. VI. Histological changes in the liver in relation to virus multiplication.
    MIMS CA
    Aust J Exp Biol Med Sci; 1957 Dec; 35(6):595-604. PubMed ID: 13522505
    [No Abstract]   [Full Text] [Related]  

  • 74. HIV-1 assembly, release and maturation.
    Freed EO
    Nat Rev Microbiol; 2015 Aug; 13(8):484-96. PubMed ID: 26119571
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Laboratory Animal Models for Rift Valley Fever Virus Disease.
    Freeman TL; McElroy AK
    Methods Mol Biol; 2024; 2824():425-445. PubMed ID: 39039428
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The search for an antiviral lead molecule to combat the neglected emerging Oropouche virus.
    Peinado RDS; Saivish MV; Menezes GL; Fulco UL; da Silva RA; Korostov K; Eberle RJ; Melo PA; Nogueira ML; Pacca CC; Arni RK; Coronado MA
    Curr Res Microb Sci; 2024; 6():100238. PubMed ID: 38745914
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Advancements in Rift Valley fever vaccines: a historical overview and prospects for next generation candidates.
    Alkan C; Jurado-Cobena E; Ikegami T
    NPJ Vaccines; 2023 Nov; 8(1):171. PubMed ID: 37925544
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Host entry factors of Rift Valley Fever Virus infection.
    Ganaie SS; Leung DW; Hartman AL; Amarasinghe GK
    Adv Virus Res; 2023; 117():121-136. PubMed ID: 37832991
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Segmented, Negative-Sense RNA Viruses of Humans: Genetic Systems and Experimental Uses of Reporter Strains.
    Hamele CE; Spurrier MA; Leonard RA; Heaton NS
    Annu Rev Virol; 2023 Sep; 10(1):261-282. PubMed ID: 37774125
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Limiting viral replication in hepatocytes alters Rift Valley fever virus disease manifestations.
    Xu L; Paine AC; Barbeau DJ; Alencastro F; Duncan AW; McElroy AK
    J Virol; 2023 Sep; 97(9):e0085323. PubMed ID: 37695055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.